DiviDrip · APLM

APLM — Apollomics, Inc.

APLM is Apollomics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $26.60. Market cap: $77M. Capital Quality Rank: 9/100 — Systemic risk.

Stock snapshot

Price$26.60
Market cap$77M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)9 / 100 · Systemic risk
Shareholder buyback yield-29.46%
Altman Z-score zoneDistress

About APLM

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.

Listed2023Employees15SectorHealthcareWebsiteapollomicsinc.com

Frequently asked

What is APLM's current stock price?

APLM (Apollomics, Inc.) is currently trading at $26.60.

Does APLM pay a dividend?

APLM (Apollomics, Inc.) does not currently pay a regular dividend.

What is APLM's Capital Quality Rank?

APLM has a Capital Quality Rank of 9/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track APLM in DiviDrip

Add APLM to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-29. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow